| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.885 | 0.005 | 0.885 | Analgesic | 0.497 0.05 CID_29981512 | ||
| 0.535 | 0.004 | 0.535 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.5 | 0.028 | 0.5 | Calcium channel L-type activator | |||
| 0.458 | 0.004 | 0.458 | Adrenaline uptake inhibitor | 0.098 0.019 CID_29981512 | ||
| 0.42 | 0.003 | 0.42 | Nitric-oxide synthase inhibitor | |||
| 0.339 | 0.004 | 0.339 | Inducible nitric-oxide synthase inhibitor | |||
| 0.31 | 0.013 | 0.31 | Antipruritic | |||
| 0.312 | 0.023 | 0.312 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.331 | 0.052 | 0.331 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.32 | 0.062 | 0.32 | Lipoxygenase inhibitor | |||
| 0.274 | 0.036 | 0.303 | Peptidyltransferase inhibitor | 0.303 0.023 CID_29981512 | CID_29981512 | |
| 0.239 | 0.004 | 0.239 | Toll-Like receptor 3 antagonist | |||
| 0.234 | 0.009 | 0.234 | Aminoacyl-tRNA synthetase inhibitor | 0.1 0.045 CID_29981512 | ||
| 0.238 | 0.016 | 0.238 | Alpha 2b adrenoreceptor antagonist | |||
| 0.231 | 0.015 | 0.231 | Antibacterial (Helicobacter pylori) | |||
| 0.29 | 0.1 | 0.29 | Transcription factor NF kappa B inhibitor | 0.249 0.128 CID_29981512 | ||
| 0.195 | 0.005 | 0.195 | TRPA1 antagonist | |||
| 0.178 | 0.004 | 0.178 | Beta adrenoreceptor antagonist | |||
| 0.317 | 0.147 | 0.325 | 5 Hydroxytryptamine release inhibitor | 0.325 0.138 CID_29981512 | CID_29981512 | |
| 0.179 | 0.009 | 0.179 | Adrenaline agonist | |||
| 0.222 | 0.056 | 0.222 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.161 | 0.009 | 0.161 | Dopamine uptake inhibitor | |||
| 0.264 | 0.121 | 0.264 | Vasodilator, coronary | 0.229 0.155 CID_29981512 | ||
| 0.161 | 0.022 | 0.161 | Nav1.5 sodium channel blocker | |||
| 0.133 | 0.005 | 0.133 | Beta 2 adrenoreceptor antagonist | |||
| 0.124 | 0.014 | 0.124 | Acetylcholine M3 receptor antagonist | |||
| 0.286 | 0.176 | 0.531 | Cyclophilin D inhibitor | 0.531 0.042 CID_29981512 | CID_29981512 | |
| 0.143 | 0.036 | 0.143 | Alpha 2c adrenoreceptor antagonist | |||
| 0.143 | 0.038 | 0.159 | DNA repair enzyme inhibitor | 0.159 0.024 CID_29981512 | CID_29981512 | |
| 0.124 | 0.019 | 0.124 | Glutamate release inhibitor | 0.086 0.072 CID_29981512 | ||
| 0.124 | 0.021 | 0.124 | Alpha 2d adrenoreceptor antagonist | |||
| 0.232 | 0.129 | 0.232 | Caspase 3 stimulant | |||
| 0.14 | 0.039 | 0.14 | Mucolytic | |||
| 0.181 | 0.085 | 0.181 | Growth factor agonist | |||
| 0.104 | 0.011 | 0.104 | Dopamine transporter inhibitor | |||
| 0.126 | 0.035 | 0.126 | Alpha 2 adrenoreceptor antagonist | |||
| 0.135 | 0.044 | 0.135 | 5-Lipoxygenase inhibitor | |||
| 0.099 | 0.01 | 0.099 | Beta 1 adrenoreceptor antagonist | |||
| 0.178 | 0.091 | 0.178 | I kappa B kinase epsilon inhibitor | |||
| 0.148 | 0.066 | 0.148 | Adenylate cyclase stimulant | |||
| 0.087 | 0.006 | 0.087 | Beta 2 adrenoreceptor agonist | |||
| 0.112 | 0.03 | 0.112 | CYP2A6 inhibitor | |||
| 0.106 | 0.03 | 0.106 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.131 | 0.057 | 0.131 | Acetylcholine muscarinic antagonist | |||
| 0.107 | 0.035 | 0.107 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.117 | 0.047 | 0.117 | Antiadrenergic | |||
| 0.072 | 0.005 | 0.072 | Dopamine autoreceptor agonist | |||
| 0.113 | 0.047 | 0.113 | Adrenaline antagonist | |||
| 0.139 | 0.076 | 0.157 | Cell wall synthesis inhibitor | 0.157 0.059 CID_29981512 | CID_29981512 | |
| 0.121 | 0.058 | 0.121 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.116 | 0.054 | 0.168 | Expectorant | 0.168 0.029 CID_29981512 | CID_29981512 | |
| 0.129 | 0.067 | 0.129 | Vanilloid 1 agonist | |||
| 0.263 | 0.202 | 0.65 | Apoptosis agonist | 0.65 0.039 CID_29981512 | CID_29981512 | |
| 0.165 | 0.104 | 0.165 | Psychostimulant | |||
| 0.073 | 0.012 | 0.073 | Squalene epoxidase inhibitor | |||
| 0.236 | 0.176 | 0.236 | 15-Lipoxygenase inhibitor | |||
| 0.153 | 0.095 | 0.153 | Neurotensin receptor agonist | |||
| 0.077 | 0.026 | 0.077 | Alpha 2 adrenoreceptor agonist | |||
| 0.069 | 0.021 | 0.12 | Factor IXa inhibitor | 0.12 0.006 CID_29981512 | CID_29981512 | |
| 0.095 | 0.049 | 0.095 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.088 | 0.043 | 0.088 | Alpha 2a adrenoreceptor antagonist | |||
| 0.181 | 0.136 | 0.181 | Spasmolytic | |||
| 0.073 | 0.03 | 0.073 | Beta 3 adrenoreceptor antagonist | |||
| 0.058 | 0.017 | 0.058 | Dopamine beta hydroxylase inhibitor | |||
| 0.053 | 0.013 | 0.053 | Beta adrenoreceptor agonist | |||
| 0.063 | 0.024 | 0.063 | 5 Hydroxytryptamine 1B agonist | |||
| 0.092 | 0.053 | 0.092 | Ornithine decarboxylase inhibitor | |||
| 0.112 | 0.074 | 0.112 | Adenylate cyclase inhibitor | |||
| 0.121 | 0.085 | 0.121 | Toll-Like receptor 9 antagonist | |||
| 0.209 | 0.176 | 0.209 | Sodium/bile acid cotransporter inhibitor | |||
| 0.143 | 0.113 | 0.143 | ATPase inhibitor | |||
| 0.098 | 0.07 | 0.098 | Urease inhibitor | |||
| 0.04 | 0.013 | 0.04 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.189 | 0.165 | 0.189 | Prostaglandin dehydrogenase inhibitor | |||
| 0.07 | 0.047 | 0.07 | Protein kinase C beta inhibitor | |||
| 0.17 | 0.147 | 0.395 | Hypoglycemic | 0.395 0.028 CID_29981512 | CID_29981512 | |
| 0.041 | 0.02 | 0.041 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.123 | 0.105 | 0.123 | Acetylcholine M1 receptor antagonist | |||
| 0.197 | 0.179 | 0.197 | Vasodilator, peripheral | |||
| 0.084 | 0.069 | 0.106 | ATPase (Vacuolar H+) inhibitor | 0.106 0.032 CID_29981512 | CID_29981512 | |
| 0.104 | 0.09 | 0.104 | Cholinergic antagonist | |||
| 0.165 | 0.152 | 0.165 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.096 | 0.083 | 0.096 | 5 Hydroxytryptamine antagonist | |||
| 0.021 | 0.009 | 0.021 | KiSS-1 receptor antagonist | |||
| 0.052 | 0.04 | 0.052 | Leukotriene B4 antagonist | |||
| 0.086 | 0.074 | 0.086 | MAO A inhibitor | |||
| 0.101 | 0.09 | 0.101 | MAO inhibitor | |||
| 0.029 | 0.018 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.014 CID_29981512 | CID_29981512 | |
| 0.019 | 0.01 | 0.019 | Alpha 2a adrenoreceptor agonist | |||
| 0.1 | 0.092 | 0.1 | Acetylcholine antagonist | |||
| 0.071 | 0.064 | 0.071 | Macrophage migration inhibitory factor inhibitor | |||
| 0.151 | 0.144 | 0.35 | Free radical scavenger | 0.35 0.039 CID_29981512 | CID_29981512 | |
| 0.206 | 0.2 | 0.206 | GABA C receptor rho-3 antagonist | |||
| 0.038 | 0.032 | 0.038 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.106 | 0.103 | 0.106 | Sodium channel (voltage-gated) blocker | |||
| 0.059 | 0.056 | 0.059 | Alpha adrenoreceptor agonist | |||
| 0.089 | 0.086 | 0.089 | Estrogen receptor beta antagonist | |||
| 0.045 | 0.043 | 0.045 | NMDA 2A receptor antagonist | |||
| 0.039 | 0.037 | 0.039 | NMDA receptor subunit 3B antagonist | |||
| 0.066 | 0.066 | 0.077 | Topoisomerase II alpha inhibitor | 0.077 0.055 CID_29981512 | CID_29981512 | |
| 0.044 | 0.053 | 0.068 | Glucose-6-phosphate translocase inhibitor | 0.068 0.017 CID_29981512 | CID_29981512 | |
| 0.171 | 0.194 | 0.228 | Cholesterol antagonist | 0.228 0.142 CID_29981512 | CID_29981512 | |
| 0.105 | 0.141 | 0.125 | Insulin secretagoues | 0.125 0.104 CID_29981512 | CID_29981512 | |
| 0.137 | 0.182 | 0.402 | Antioxidant | 0.402 0.035 CID_29981512 | CID_29981512 | |
| 0.134 | 0.181 | 0.818 | Vasodilator | 0.818 0.003 CID_29981512 | CID_29981512 | |
| 0.014 | 0.062 | 0.031 | Sodium/glucose cotransporter 2 inhibitor | 0.031 0.012 CID_29981512 | CID_29981512 | |
| 0.191 | 0.241 | 0.679 | Antibacterial | 0.679 0.01 CID_29981512 | CID_29981512 | |
| 0.11 | 0.16 | 0.137 | Melanin inhibitor | 0.137 0.101 CID_29981512 | CID_29981512 | |
| 0.113 | 0.165 | 0.293 | Hepatoprotectant | 0.293 0.032 CID_29981512 | CID_29981512 | |
| 0.024 | 0.078 | 0.06 | Antibiotic Aminoglycoside-like | 0.06 0.009 CID_29981512 | CID_29981512 | |
| 0.013 | 0.07 | 0.027 | Protein 30S ribosomal subunit inhibitor | 0.027 0.014 CID_29981512 | CID_29981512 | |
| 0.013 | 0.09 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.018 CID_29981512 | CID_29981512 | |
| 0.029 | 0.108 | 0.291 | Selectin antagonist | 0.291 0.006 CID_29981512 | CID_29981512 | |
| 0.027 | 0.146 | 0.165 | Nitric oxide donor | 0.165 0.002 CID_29981512 | CID_29981512 | |
| 0.023 | 0.159 | 0.092 | Antineoplastic antibiotic | 0.092 0.05 CID_29981512 | CID_29981512 | |
| 0.085 | 0.222 | 0.216 | Nitric oxide antagonist | 0.216 0.062 CID_29981512 | CID_29981512 | |
| 0.149 | 0.299 | 0.309 | Interleukin 2 agonist | 0.309 0.067 CID_29981512 | CID_29981512 | |
| 0.131 | 0.282 | 0.264 | Antithrombotic | 0.264 0.115 CID_29981512 | CID_29981512 | |
| 0.061 | 0.235 | 0.664 | Angiogenesis stimulant | 0.664 0.005 CID_29981512 | CID_29981512 | |
| 0.031 | 0.227 | 0.092 | Topoisomerase I inhibitor | 0.092 0.077 CID_29981512 | CID_29981512 | |
| 0.016 | 0.227 | 0.073 | Protein 50S ribosomal subunit inhibitor | 0.073 0.022 CID_29981512 | CID_29981512 | |
| 0.068 | 0.291 | 0.147 | NOS3 expression enhancer | 0.147 0.075 CID_29981512 | CID_29981512 | |
| 0.062 | 0.31 | 0.157 | Immunostimulant | 0.157 0.148 CID_29981512 | CID_29981512 | |
| 0.113 | 0.38 | 0.236 | Apoptosis antagonist | 0.236 0.142 CID_29981512 | CID_29981512 | |
| 0.055 | 0.351 | 0.25 | Platelet adhesion inhibitor | 0.25 0.049 CID_29981512 | CID_29981512 | |
| 0.041 | 0.356 | 0.083 | Transcription factor NF kappa B stimulant | 0.083 0.063 CID_29981512 | CID_29981512 | |
| 0.12 | 0.478 | 0.281 | Antiinflammatory | 0.281 0.233 CID_29981512 | CID_29981512 | |
| 0.031 | 0.421 | 0.159 | Anticoagulant | 0.159 0.073 CID_29981512 | CID_29981512 | |
| 0.019 | 0.512 | 0.181 | Thrombolytic | 0.181 0.062 CID_29981512 | CID_29981512 | |
| 0.024 | 0.538 | 0.552 | Platelet antagonist | 0.552 0.009 CID_29981512 | CID_29981512 | |
| 0.025 | 0.546 | 0.099 | Toll-Like receptor 4 antagonist | 0.099 0.072 CID_29981512 | CID_29981512 | |
| 0.022 | 0.687 | 0.189 | Angiogenesis inhibitor | 0.189 0.183 CID_29981512 | CID_29981512 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |